Connect with us

Technology

Why woolly mice won’t bring back mammoths or save endangered species

Published

on

Why woolly mice won’t bring back mammoths or save endangered species


US company Colossal Biosciences has announced the creation of a “woolly mouse” — a laboratory mouse with a series of genetic modifications that lead to a woolly coat.
| Photo Credit: Colossal Biosciences/The Conversation

US company Colossal Biosciences has announced the creation of a “woolly mouse” — a laboratory mouse with a series of genetic modifications that lead to a woolly coat. The company claims this is the first step toward “de-extincting” the woolly mammoth.

The successful genetic modification of a laboratory mouse is a testament to the progress science has made in understanding gene function, developmental biology and genome editing. But does a woolly mouse really teach us anything about the woolly mammoth?

What has been genetically modified?

Woolly mammoths were cold-adapted members of the elephant family, which disappeared from mainland Siberia at the end of the last Ice Age around 10,000 years ago. The last surviving population, on Wrangel Island in the Arctic Ocean, went extinct about 4,000 years ago.

The house mouse (Mus musculus) is a far more familiar creature, which most of us know as a kitchen pest. It is also one of the most studied organisms in biology and medical research. We know more about this laboratory mouse than perhaps any other mammal besides humans.

Colossal details its new research in a pre-print paper, which has not yet been peer-reviewed. According to the paper, the researchers disrupted the normal function of seven different genes in laboratory mice via gene editing.

Six of these genes were targeted because a large body of existing research on the mouse model had already demonstrated their roles in hair-related traits, such as coat colour, texture and thickness.

The modifications in a seventh gene — FABP2 — was based on evidence from the woolly mammoth genome. The gene is involved in the transport of fats in the body.

Woolly mammoths had a slightly shorter version of the gene, which the researchers believe may have contributed to its adaptation to life in cold climates. However, the “woolly mice” with the mammoth-style variant of FABP2 did not show significant differences in body mass compared to regular lab mice.

What would it mean to de-extinct a species?

This work shows the promise of targeted editing of genes of known function in mice. After further testing, this technology may have a future place in conservation efforts. But it’s a long way from holding promise for de-extinction.

Colossal Biosciences claims it is on track to produce a genetically modified “mammoth-like” elephant by 2028, but what makes a mammoth unique is more than skin-deep.

De-extinction would need to go beyond modifying an existing species to show superficial traits from an extinct relative. Many aspects of an extinct species’ biology remain unknown. A woolly coat is one thing. Recreating the entire suite of adaptations, including genetic, epigenetic and behavioural traits that allowed mammoths to thrive in ice age environments, is another.

Unlike the thylacine (or Tasmanian tiger) — another species Colossal aims to resurrect — the mammoth has a close living relative in the modern Asian elephant. The closer connections between the genomes of these two species may make mammoth de-extinction more technically feasible than that of the thylacine.

But whether or not a woolly mouse brings us any closer to that prospect, this story forces us to consider some important ethical questions. Even if we could bring back the woolly mammoth, should we? Is the motivation behind this effort conservation, or entertainment? Is it ethical to bring a species back into an environment that may no longer sustain it?

Focus on conserving what remains

In Australia alone, we’ve lost at least 100 species to extinction since European colonisation in 1788, largely due the introduction of feral predators and land clearing.

The idea of reversing extinction is understandably appealing. We might like to think we could undo the past.

According to Colossal’s website, “Extinction is a colossal problem facing the world. And Colossal is the company that’s going to fix it.”

It’s hard to argue with the first part of that. But focusing on bringing back extinct species distracts from a more urgent reality: species are going extinct right now, and we are not doing enough to save them.

We should first focus on promises to save surviving species, rather than promises to bring back the dead.

With more investment in threatened species monitoring, new pest control methods, and conservation genetic management, we can turn the tide of extinction and secure the future for species that remain.

There’s a long list of threatened species that are still alive now. With the right funding and conservation attention, we can do something to save them before it’s too late.

Emily Roycroft am an evolutionary biologist, and Head of the Evolutionary & Conservation Genomics Research Group at Monash University. This article is republished from The Conversation.



Source link

Technology

Yahoo ready to buy Chrome browser if Google is forced to sell

Published

on

Yahoo ready to buy Chrome browser if Google is forced to sell


Apr 25, 2025 03:44 AM IST

The Justice Department and a group of US states have argued that Google should be forced to sell off its popular Chrome browser.

Internet company Yahoo Inc. — backed by owner Apollo Global Management Inc. — would bid for the Chrome web browser if a federal court orders Google to divest it as a remedy for maintaining an illegal monopoly, a senior executive said.

Google Chrome logo is seen near cyber code and words “spy” in this illustration picture taken June 18, 2020.(Reuters)

Brian Provost, the general manager for Yahoo Search, testified Thursday during Google’s trial in Washington that his company estimates the browser would have a sale price in the tens of billions of dollars.

Chrome is “arguably the most important strategic player on the web,” Provost said. “We would be able to pursue it with Apollo.”

Provost testified as part of a three-week hearing in the Justice Department’s case against Alphabet Inc.’s Google to determine how to remedy the company’s monopoly in internet search. Judge Amit Mehta ruled last year Google illegally monopolized the market and is contemplating a package of changes proposed by antitrust enforcers.

Also Read | OpenAI would buy Google’s Chrome browser, says ChatGPT chief Nick Turley

The Justice Department and a group of US states have argued that Google should be forced to sell off its popular Chrome browser.

Yahoo was the leading search engine in the early 2000s before losing that position to Google. The company has changed hands several times; Apollo purchased it in 2021 from Verizon Communications Inc.

Since the Apollo takeover, Yahoo has been seeking to “revitalize” its search engine, and started building its own browser that remains in development, Provost said. The company has also considered buying a browser and became interested in purchasing Chrome as soon as the Justice Department’s proposal became public, he said.

Yahoo would likely have competition. OpenAI also would be interested in buying Chrome browser, the head of ChatGPT said during the trial Tuesday.

“Yes, we would, as would many other parties,” Nick Turley, OpenAI’s ChatGPT chief, said in response to a question about whether the company would seek to buy Google’s browser.



Source link

Continue Reading

Technology

Experiments in Axiom mission to ISS to study if diabetics can stay in space

Published

on

From The Hindu, April 25, 1975: Israel’s independence — Soviet offer


Can insulin-dependent diabetics stay in space? This will be one of the areas of research by astronauts who will fly to the International Space Station (ISS), probably this May, as part of the Axiom 4 mission. Indian Air Force pilot, Shubhanshu Shukla, will be among the four astronauts part of the space-flight – the first time an Indian will fly to the ISS.

The larger thrust of the experiment is to demonstrate that astronauts with insulin-dependent diabetes can be supported for short duration stays in microgravity. This can be done by demonstrating accurate blood glucose testing, data transmission, and insulin viability on the ISS. This research will also help enable people with diabetes to participate in future space missions, thus expanding the eligibility of crew and expanding access to space to more people. The project is being undertaken in partnership with Burjeel Holdings PLC, a United Arab Emirates-based healthcare services provider, said a statement from Axiom. The company organises commercial flights to the ISS and is also in the process of building the first private space station. The lead investigators on the study are John Marshall and Alex Rubin, affiliated to Axiom.

Beyond the “micro-gravity” environment in a space station, the insights gained could potentially improve healthcare delivery on earth, particularly in remote and extreme environments. The technology used in orbit could enable remote monitoring and treatment of oil rig workers with chronic conditions at sea, adventurers with chronic conditions in extreme environments, and even patients receiving care at home, Burjeel said in a statement.

Astronauts on the ISS spend a substantial amount of time conducting a slew of experiments and gathering data on how ordinary biological process are altered by micro-gravity. “Studying biological processes in microgravity offers unique opportunities to understand diseases in ways that are impossible to replicate on Earth. The absence of gravity alters cellular behaviour, enabling deeper insights into conditions such as Alzheimer’s, Parkinson’s, and cancer. Previous research in space has already contributed to significant insights in protein crystallization and cellular ageing,” it added.

Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, underscored the significance of this collaboration, stating, “Burjeel Holdings is proud to collaborate on this groundbreaking study aboard Ax-4, which marks a milestone in medical research and diabetes management. The findings from this study have the potential to not only benefit future astronauts but also translate into meaningful advancements in patient care here on the ground.”



Source link

Continue Reading

Technology

iPhone 17 Air: Apple’s risky new star may steal the bling from the Pro line

Published

on

iPhone 17 Air: Apple’s risky new star may steal the bling from the Pro line


iPhone 17 Air will reportedly make its debut this autumn and with it, Apple may be preparing to disrupt its own premium lineup, and possibly by design. This ultra-thin iPhone, a clear replacement for the underwhelming Plus model, has been the subject of persistent leaks. But what’s truly turned heads is a recent Unbox Therapy hands-on with a dummy unit. Tech reviewer Lew Hilsenteger, a seasoned veteran in the gadget world, was unexpectedly floored. “That feels futuristic,” he remarked, conveying genuine surprise despite following the rumours for months.

The iPhone 17 Air, by all early impressions, does not look like just another iteration. (Unbox Therapy)

The moment underscored something essential: seeing (and feeling) is believing. The iPhone 17 Air, by all early impressions, is not just another iteration. It’s something else, perhaps the first visually exciting iPhone since the X.

A Threat to the Pro Line?

Here’s the catch: the iPhone 17 Air likely won’t be Apple’s most expensive phone. That title will still belong to the Pro and Pro Max. But if the Air proves as seductive in hand as it appears in leaks, Apple risks cannibalising its own high-margin flagship line.

Why spend more on the Pro when the Air is thinner, sleeker, and just as capable for most users?

It’s a fair concern. But also, potentially, a calculated one.

Betting on Excitement Over Margins

The truth is, Apple needs a hit, not financially, but culturally. For years now, iPhone design has plateaued. The 15 Pro is a phenomenal device, but it doesn’t feel new. The last time Apple truly reset expectations was in 2017 with the iPhone X. The iPhone 17 Air won’t be quite as revolutionary. But it could deliver something Apple hasn’t achieved in years: buzz. The kind of buzz that fuels lines outside stores, envious stares across cafe tables, and the irresistible need to upgrade.

In short, the Air could reignite passion for the iPhone.

And if it means shaving a few billion off Pro model sales in the short term? Apple may be willing to take the hit—because the long-term gain is loyalty, excitement, and momentum heading into the next big thing (iPhone Fold, anyone?).

Will It Cannibalise Pro Sales?

The Pro line has long justified its price with features like ProMotion, triple lenses, and titanium builds. But if the Air looks and feels fresher, lighter, and more “2025,” casual buyers and even some power users could opt for form over function. The wild card will be pricing and performance. If Apple gives the Air a high-end chip and flagship-level display, all while keeping it competitively priced, the Pro models might feel redundant to all but the most hardcore enthusiasts.



Source link

Continue Reading

Trending

Copyright © 2025 Republic Diary. All rights reserved.